104 results
8-K
EX-4.3
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation
8-K
EX-4.1
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation
8-K
EX-4.2
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
f
8-K
EX-4.1
ldu2kj 0mkqa90
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K/A
EX-10.1
6080arw7obcgta7z0
22 Aug 23
Departure of Directors or Certain Officers
8:30am
S-8
EX-99.1
nbvnhpueibfnf
9 Jun 23
Registration of securities for employees
5:19pm
8-K
EX-4.1
npjvqh
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.9
pnyj52v pv4ihsee
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.4
avxth3l39 vzundxq1zi
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.2
lav614
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.5
i6j uz3p65vuul56w
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
zwzdu2z4
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm